All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Mon 2012-12-10? to Fri 2025-11-28 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+28.25%
2025-11-28 |
7.706 TRR
2025-11-28 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10? to Fri 2025-11-28 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+670.56%
+17.06%/yr |
+14.40%/yr
(R2=0.946) |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10? to Fri 2025-11-28 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$77,055.84
2025-11-28 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Year | ABBV |
|---|---|
| 2025 (YTD) | +28.25% |
| 2024 | +15.54% |
| 2023 | −3.47% |
| 2022 | +16.48% |
| 2021 | +23.72% |
| 2020 | +26.01% |
| 2019 | −0.80% |
| 2018 | −2.80% |
| 2017 | +56.75% |
| 2016 | +7.57% |
| 2015 | −7.18% |
| 2014 | +26.97% |
| 2013 | +58.39% |
| 2012 | −2.23% |
| Mon 2012-12-10? to Fri 2025-11-28 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ABBV × | −6.60% |
−47.00%
2019-08-15 |
||||
| AbbVie Inc NYSE Common Stock | ||||||